Skip to product information
1 of 1

Cloud-clone

SKU:RPC688Mu02

Recombinant Osteoglycin (OGN)

Recombinant Osteoglycin (OGN)

Regular price $308.00 USD
Regular price Sale price $308.00 USD
Sale Sold out
Shipping calculated at checkout.
UOM
Purity
Organism species

Prokaryotic expression

Product No.

RPC688Mu02

Organism Species

Mus musculus (Mouse).

Source

Prokaryotic expression

Host

E.coli

Endotoxin Level

<1.0EU per 1µg (determined by the LAL method)

Subcellular Location

n/a

Predicted Molecular Mass

n/a

Accurate Molecular Mass

n/a(Analysis of differences refer to the manual)

Residues & Tags

N-terminal His Tag

Buffer Formulation

PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

Traits

Freeze-dried powder

Purity

> 97%

Isoelectric Point

n/a

Applications

Positive Control; Immunogen; SDS-PAGE; WB.

If bio-activity of the protein is needed, please check active protein.

UOM

10µg 50µg 200µg 1mg 5mg

SEQUENCE

 

USAGE

Reconstitute in PBS or others.

STORAGE

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Magazine Citations
Bone. Association of osteoglycin and FAM5C with bone turnover markers, bone mineral density, and vertebral fractures in postmenopausal women with type 2 diabetes mellitus. pubmed:27836731
Tohoku journal of experimental medicine Higher Serum Levels of Osteoglycin Are Associated with All-Cause Mortality and Cardiovascular and Cerebrovascular Events in Patients with Advanced Chronic Kidney Disease. pubmed:28824047
Molecular Metabolism Osteoglycin, a novel coordinator of bone and glucose homeostasis Pubmed:29799418
Journal of Experimental & Clinical Cancer Research Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway Pubmed:29499765
Journal of Human Hypertension Association of SLRPs with carotid artery atherosclerosis in essential hypertensive patients Pubmed:29867136
Cell Reports Transforming Growth Factor-β3 Regulates Adipocyte Number in Subcutaneous White Adipose Tissue Pubmed: 30332637
J Clin Endocrinol Metab Osteoglycin across the adult lifespan 34850904
Catalog No. Related products for research use of Mus musculus (Mouse) Organism species Applications (RESEARCH USE ONLY!)
RPC688Mu02 Recombinant Osteoglycin (OGN) Positive Control; Immunogen; SDS-PAGE; WB.
RPC688Mu01 Recombinant Osteoglycin (OGN) Positive Control; Immunogen; SDS-PAGE; WB.
PAC688Mu01 Polyclonal Antibody to Osteoglycin (OGN) WB; IHC; ICC; IP.
PAC688Mu02 Polyclonal Antibody to Osteoglycin (OGN) WB; IHC; ICC; IP.
LAC688Mu71 Biotin-Linked Polyclonal Antibody to Osteoglycin (OGN) WB; IHC; ICC.
SEC688Mu ELISA Kit for Osteoglycin (OGN) Enzyme-linked immunosorbent assay for Antigen Detection.
LMC688Mu Magnetic Luminex Assay Kit for Osteoglycin (OGN) ,etc. Magnetic Luminex Assay for Antigen Detection.
View full details